Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.
about
Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.Expression of Interleukin-26 is upregulated in inflammatory bowel disease.Indole microbial metabolites: expanding and translating target(s).Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells.Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.A single extracellular amino acid in Free Fatty Acid Receptor 2 defines antagonist species selectivity and G protein selection bias.Impact of Omega-3 Fatty Acids on the Gut Microbiota.Effects of Lactobacillus acidophilus on gut microbiota composition in broilers challenged with Clostridium perfringens.Analysis of the gut microbiome and plasma short-chain fatty acid profiles in a spontaneous mouse model of metabolic syndrome.Novel probiotics isolated from a Japanese traditional fermented food, Funazushi, attenuates DSS-induced colitis by increasing the induction of high integrin αv/β8-expressing dendritic cells.Gut microbiota in the pathogenesis of inflammatory bowel disease.Development of a fast and cost-effective gas chromatography-mass spectrometry method for the quantification of short-chain and medium-chain fatty acids in human biofluids.Dietary therapy may be sufficient for type 1 diabetes treatment.Frontline defenders: Goblet cell mediators dictate host-microbe interactions in the intestinal tract during health and disease.Umbilical cord blood mononuclear cell therapy induces clinical remission of steroid-dependent or -resistant ulcerative colitis patients.Peripheral N-methyl-D-aspartate receptor localization and role in gastric acid secretion regulation: immunofluorescence and pharmacological studies.Implication of G Protein-Coupled Receptor 43 in Intestinal Inflammation: A Mini-Review.Diet, Microbiota and Gut-Lung ConnectionHuman-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiomeHeme Oxygenase-1 as a Modulator of Intestinal Inflammation Development and ProgressionMicrobiota-derived short-chain fatty acids promote Th1 cell IL-10 production to maintain intestinal homeostasisRhamnogalacturonan, a chemically-defined polysaccharide, improves intestinal barrier function in DSS-induced colitis in mice and human Caco-2 cells
P2860
Q33906911-A5AA2772-457B-454D-B98C-125DEA520A92Q41426315-E9C013AD-C71D-45B0-A57A-FE080E45CD79Q42353071-E3FF9C39-AFB9-4014-A11D-6FE7EB75A283Q42371410-2F62C85F-5F43-4939-806C-9BA7301B39ACQ44348130-50A945DB-DD45-4406-A017-7B3783F88CD8Q45835944-1B722AC7-19B2-4E7D-8F96-33CA803EFC55Q46246072-385E0EC1-DB11-47E9-B513-B2098F233D2BQ46251016-564814B2-B1F9-43C9-80BC-97E649B6CBF5Q46257613-311C5708-43DB-40B6-B60E-B47F13AD5179Q46347544-63E84A97-E805-4C6E-B29A-D393BA70E2DAQ47236027-DC8DA744-9B3C-4E96-9F15-6E7EA5442762Q47968131-CEC4E33A-6C35-478C-BD3C-4701863DDD1DQ48155821-EEF32E4E-E8A8-40F3-88C5-A1E9F973F46FQ50084713-7BA43FA2-4734-433C-A3B2-698AAF73CDEBQ53277640-3C128069-F66D-498A-83DD-93D1BBFBD8ECQ54962605-1F1DE819-1C02-4D48-A648-0E1DAA38AA12Q55498040-95B56592-FC73-4CE3-BB81-ABEFCED72D81Q57072837-9536E843-D4CC-40B6-AEDA-CED823EAA5A8Q58714655-81F5AC23-4A96-4109-B5C0-CF325073B0E3Q58746575-33F4DD69-D644-4D80-9E0B-5A22D8409EFEQ58769405-4304E528-C671-4717-A204-010953BA22E6Q58774564-DFF6B52C-5515-43A3-8ECA-D70CDD52A49B
P2860
Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.
@en
type
label
Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.
@en
prefLabel
Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.
@en
P2093
P2860
P1476
Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.
@en
P2093
P2860
P356
10.1007/S00535-016-1242-9
P50
P577
2016-07-23T00:00:00Z